EGF-mediated EGFR/ERK signaling pathway promotes germinative cell proliferation in Echinococcus multilocularis that contributes to larval growth and development

PLoS Neglected Tropical Diseases
Zhe ChengYanhai Wang

Abstract

Larvae of the tapeworm E. multilocularis cause alveolar echinococcosis (AE), one of the most lethal helminthic infections in humans. A population of stem cell-like cells, the germinative cells, is considered to drive the larval growth and development within the host. The molecular mechanisms controlling the behavior of germinative cells are largely unknown. Using in vitro cultivation systems we show here that the EGFR/ERK signaling in the parasite can promote germinative cell proliferation in response to addition of human EGF, resulting in stimulated growth and development of the metacestode larvae. Inhibition of the signaling by either the EGFR inhibitors CI-1033 and BIBW2992 or the MEK/ERK inhibitor U0126 impairs germinative cell proliferation and larval growth. These data demonstrate the contribution of EGF-mediated EGFR/ERK signaling to the regulation of germinative cells in E. multilocularis, and suggest the EGFR/ERK signaling as a potential therapeutic target for AE and perhaps other human cestodiasis.

References

Apr 4, 1997·Science·G K Michalopoulos, M C DeFrances
Jan 17, 2004·Clinical Microbiology Reviews·Johannes Eckert, Peter Deplazes
Jul 3, 2004·The Journal of Biological Chemistry·Jerome VicogneColette Dissous
Jun 15, 2007·Journal of Cellular Physiology·George K Michalopoulos
Dec 14, 2007·Annual Review of Genetics·Jason Pellettieri, Alejandro Sánchez Alvarado
Feb 15, 2008·Proceedings of the National Academy of Sciences of the United States of America·Adrian Salic, Timothy J Mitchison
Sep 26, 2008·Parasite : Journal De La Société Française De Parasitologie·K Brehm, M Spiliotis
Dec 19, 2009·BMC Developmental Biology·Katrien De MulderPeter Ladurner
Jan 19, 2010·Development, Growth & Differentiation·Norito ShibataKiyokazu Agata
Mar 13, 2012·Annual Review of Biophysics·Yubing SunJianping Fu
Sep 6, 2012·International Journal of Antimicrobial Agents·Sarah Hemer, Klaus Brehm
Nov 10, 2012·Development Genes and Evolution·Jochen C Rink
Feb 22, 2013·Nature·James J CollinsPhillip A Newmark
Mar 6, 2013·PLoS Pathogens·Christina M TaylorMakedonka Mitreva
Jun 6, 2014·PLoS Neglected Tropical Diseases·Andreas SchubertKlaus Brehm
Oct 4, 2014·Cell Stem Cell·Jamie A Hackett, M Azim Surani
Dec 20, 2014·Parasite : Journal De La Société Française De Parasitologie·Klaus Brehm, Uriel Koziol
Jan 18, 2015·Cellular and Molecular Life Sciences : CMLS·Guanyi HuangQi-Long Ying
Jan 27, 2015·Journal of Genetics and Genomics = Yi Chuan Xue Bao·Zhouhua LiYu Cai
Aug 25, 2015·Veterinary Parasitology·U Koziol, K Brehm
Aug 16, 2016·Developmental Cell·Kai LeiAlejandro Sánchez Alvarado

❮ Previous
Next ❯

Citations

Jul 18, 2020·BMC Genomics·Gabriela Prado PaludoHenrique Bunselmeyer Ferreira
Jul 10, 2019·IUBMB Life·Tanushree Mukherjee, Kithiganahalli Narayanaswamy Balaji

❮ Previous
Next ❯

Methods Mentioned

BETA
ELISA
glycosylation

Related Concepts

Related Feeds

Anthelmintics (ASM)

Anthelmintics or antihelminthics are a group of antiparasitic drugs that expel parasitic worms (helminths) and other internal parasites from the body by either stunning or killing them and without causing significant damage to the host. Discover the latest research on anthelmintics here.

Anthelmintics

Anthelmintics or antihelminthics are a group of antiparasitic drugs that expel parasitic worms (helminths) and other internal parasites from the body by either stunning or killing them and without causing significant damage to the host. Discover the latest research on anthelmintics here.